Radiation Oncology

Radiation oncology is a medical specialty that uses radiation therapy to treat cancer. The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

News | Coronavirus (COVID-19)
Cancer vs. COVID: When a Pandemic Upended Cancer Care

August 7, 2020 — When COVID-19 struck, health care pivoted hard. Any unnecessary procedures or appointments were ...

Time August 07, 2020
arrow
Global radiotherapy market revenue is set to expand from $7,222.4 million in 2019 to $17,194.4 million by 2030, at an 8.4% CAGR between 2020 and 2030, the key factor driving the market growth is the increasing number of cancer cases, according to the report published by P&S Intelligence.
News | Radiation Therapy
Radiotherapy Market to Cross $17 Million Revenue by 2030

August 6, 2020 — Global radiotherapy market revenue is set to expand from $7,222.4 million in 2019 to $17,194.4 million ...

Time August 06, 2020
arrow
According to the new market research report "Radiation Dose Management Market by Products & Services (Standalone Solutions, Integrated Solutions, Services), Modality (Computed Tomography, Nuclear Medicine), Application (Oncology, Cardiology, Orthopedic), End User (Hospitals) - Global Forecast to 2025", published by MarketsandMarkets, the radiation dose management market is projected to reach USD 422.65 million by 2025 from USD 220.22 million in 2020, at a CAGR of 13.9%.
News | Radiation Dose Management
Radiation Dose Management Market worth $422.65 million by 2025

August 3, 2020 — According to the new market research report "Radiation Dose Management Market by Products & Services ...

Time August 03, 2020
arrow
Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly welcomes Siemens Healthineers AG’s acquisition of a 100 percent stake in Varian Medical Systems, Inc., a U.S. company active in the area of cancer research and therapy.
News | Radiology Business
Siemens Healthineers Set to Acquire Varian in $16.4B Deal

August 3, 2020 — Siemens AG is continuing to rigorously execute its Vision 2020+ strategy and therefore expressly ...

Time August 03, 2020
arrow
JAMA Oncol. Published online July 30, 2020. doi:10.1001/jamaoncol.2020.2783
News | Coronavirus (COVID-19)
Outcomes in Radiotherapy-treated Patients with Cancer During COVID-19

July 31, 2020 — An article published in JAMA Oncology addresses the delivery of radiotherapy in 209 patients with cancer ...

Time July 31, 2020
arrow
Older Americans may be receiving cancer screenings not recommended by the U.S. Preventive Services Task Force, according to Penn State College of Medicine researchers.
News | Radiology Imaging
Older Americans Receive Cancer Screenings Past Recommended Age

July 31, 2020 — Older Americans may be receiving cancer screenings not recommended by the U.S. Preventive Services Task ...

Time July 31, 2020
arrow
Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, and ImaginAb, Inc., a company that harnesses the specificity of monoclonal antibodies, have entered into a collaboration agreement to develop new targeted theranostic (diagnostic and therapy) products for a broad range of cancer types.
News | Radiation Oncology
Clarity Pharmaceuticals and ImaginAb Collaborate on New Cancer Targets

July 29, 2020 — Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, and ...

Time July 29, 2020
arrow
It has been estimated that the overwhelming focus on COVID-19 could cause up to 35,000 excess cancer deaths in the UK during the next 12 months, and  Zegami, the Oxford University data visualization spin-out which has worked on several projects focused on the detection, diagnosis, or management of cancer, is calling for greater use of technology to speed up the process of diagnosis and treatment.
News | Radiation Oncology
Better Use of Technology Needed to Address Coronavirus-fueled Backlog in Cancer Diagnosis

July 29, 2020 — It has been estimated that the overwhelming focus on COVID-19 could cause up to 35,000 excess cancer ...

Time July 29, 2020
arrow
Prostate biopsy with cancer probability (blue is low, red is high). This case was originally diagnosed as benign but changed to cancer upon further review. The AI accurately detected cancer in this tricky case. Image courtesy of Ibex Medical Analytics
News | Prostate Cancer
Artificial Intelligence Identifies Prostate Cancer with Near-perfect Accuracy

July 28, 2020 — A study published in The Lancet Digital Health by UPMC and University of Pittsburgh researchers ...

Time July 28, 2020
arrow
Zebra Medical Vision announced its sixth FDA 510(k) clearance for its mammography solution, HealthMammo, which has already received a CE mark. Zebra Medical’s algorithm empowers breast radiologists by prioritizing and identifying suspicious mammograms, providing a safety net for radiologists. The suspicious mammograms are identified faster and read earlier than the current “first-in first-out” standard of care. 
News | Breast Imaging
Zebra Medical Vision Secures its First FDA Clearance in Oncology

July 26, 2020 — Zebra Medical Vision announced its sixth FDA 510(k) clearance for its mammography solution, HealthMammo ...

Time July 27, 2020
arrow
(a) A schematic of cycloidal computed tomography (not to scale, seen from top); by adding an array of beam stops in front of the detector, the setup is transformed into an edge-illumination x-ray phase-contrast imaging device. (b) A sinogram sampling grid for a rotation-only scheme. (c) A sinogram sampling grid for a cycloidal scheme. The grids are shown for one mask period and a subset of rotation angles; the combination of empty and filled circles shows the grids that would be achieved through fine latera
News | Computed Tomography (CT)
New CT Scan Method Lowers Radiation Exposure

July 24, 2020 — A computed tomography (CT) scan technique that splits a full X-ray beam into thin beamlets can deliver ...

Time July 24, 2020
arrow
In I-131 cancer therapy, decay events damage sensitive DNA within a tumor cell nucleus, causing catastrophic single and double strand breaks. Clinical use of antibody-delivered Auger emitters could open a window for the targeted destruction of extracellular COVID-19 virions, decreasing the viral load during active infection and potentially easing the disease burden for a patient. View all figures from this study. http://jnm.snmjournals.org/content/early/2020/07/16/jnumed.120.249748.full.pdf+html
News | Coronavirus (COVID-19) | Dave Fornell, Editor
Radiation Therapy Might be a Treatment Option for COVID-19

July 22, 2020 — One of the first studies has been published that looks at the use of radiation therapy to help treat ...

Time July 22, 2020
arrow
 A Ludwig Cancer Research study has dissected how radiotherapy alters the behavior of immune cells known as macrophages found in glioblastoma (GBM) tumors and shown how these cells might be reprogrammed with an existing drug to suppress the invariable recurrence of the aggressive brain cancer.
News | Radiation Therapy
Study Finds Reprogramming of Immune Cells Enhances Effects of Radiotherapy in Preclinical Models of Brain Cancer

July 22, 2020 — A Ludwig Cancer Research study has dissected how radiotherapy alters the behavior of immune cells known ...

Time July 22, 2020
arrow
The radiology and molecular imaging fields mourn the loss of another brilliant leader, Sanjiv Sam Gambhir, M.D., Ph.D.
News | Radiology Business
The Industry Mourns the Loss of Sanjiv Sam Gambhir, M.D., Ph.D.

July 20, 2020 — The radiology and molecular imaging fields mourn the loss of another brilliant leader. Sanjiv Sam ...

Time July 20, 2020
arrow
"Our study demonstrates that a real-world lung cancer screening can perform similar to randomized controlled trials in regard to important performance metrics," the UPenn authors of this AJR article concluded. Image courtesy of American Journal of Roentgenology (AJR)
News | Lung Imaging
Improving Lung Cancer CT Screening Performance in Real-world Settings

July 17, 2020 — An online first accepted manuscript published in ARRS' American Journal of Roentgenology (AJR) finds ...

Time July 17, 2020
arrow
PSMA PET/CT accurately detects recurrent prostate cancer in 67-year-old man. 18F-DCFPyL-PSMA PET/CT shows extensive, intensely PSMA-avid local recurrence in prostate (bottom row; solid arrow) in keeping with the known tumor recurrence in the prostate. Right: PET shows extensive, intensely PSMA-avid local recurrence in prostate (top row; solid arrow) and a solitary bone metastasis in left rib 2 (bottom row; dotted arrow). Image courtesy of Ur Metser, et al.
News | PET-CT
PSMA PET/CT Can Change Management in Recurrent Prostate Cancer

July 16, 2020 — New research confirms the high impact of PSMA PET/CT in the detection and management of recurrent ...

Time July 16, 2020
arrow
Total-body dynamic 18F-FDG PET imaging with the uEXPLORER scanner allows us to monitor the spatiotemporal distribution of glucose concentration in metastatic tumors in the entire body (a). As compared to a typical clinical standardized uptake value image (b), the parametric image of FDG influx rate (Ki) can achieve higher lesion-to-background (e.g., the liver) contrast. In addition to glucose metabolism imaging by Ki, total-body dynamic PET also enables multiparametric characterization of tumors and organs
News | PET Imaging
Total-body Dynamic PET Successfully Detects Metastatic Cancer

July 16, 2020 — Results from the first study using uEXPLORER to conduct total-body dynamic positron emission tomography ...

Time July 16, 2020
arrow
PET/CT imaging showing uptake and retention of 86Y-NM600 (imaging agent) in immunocompetent mice bearing prostate tumors. PET imaging data was employed to estimate tumor dosimetry and prescribe an immunomodulatory 90Y-NM600 (therapy agent) injected activity. Image courtesy of R Hernandez et al., University of Wisconsin-Madison, WI.
News | PET-CT
Targeted Radionuclide Therapy Enhances Prostate Cancer Response to Immunotherapies

July 15, 2020 — Targeted radionuclide therapy has been found to create a favorable tumor microenvironment in prostate ...

Time July 15, 2020
arrow
World's largest radiation oncology meeting will offer full conference on interactive platform October 25-28, 2020
News | ASTRO
ASTRO to Host Virtual Annual Meeting in October

July 9, 2020 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 62nd Annual Meeting ...

Time July 09, 2020
arrow
Simulation finds starting at age 30 with MRI and mammography to be the preferred strategy; starting at 25 prevented marginally more deaths, but with more testing and emotional stress
News | Breast Imaging
When and How to Monitor for Breast Cancer After Childhood Chest Radiation

July 9, 2020 — Chest radiation is used to treat children with Hodgkin and non-Hodgkin lymphoma as well as lung ...

Time July 09, 2020
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now